Atlanta Clinical and Translational Science Institute (ACTSI) Renewal

为了实现CTSA的愿景，对质量和价值产生持续和变革性的影响， 临床和转化研究，来自三个学术机构的领导-埃默里大学，莫尔豪斯 医学院，和格鲁吉亚理工学院，沿着与其他合作组织组成 2007年，亚特兰大临床和转化科学研究所（ACTSI）。ACTSI整合了 发现，教育，培训和社区参与计划，并产生了前所未有的 我们社区的临床和转化研究的转化水平。ACTSI开发了一个 亚特兰大通过支持临床和转化研究的“家”：673名研究人员，520个项目，93个 96个研究领域的试点项目、超过193项联邦（PHS）赠款、134项现任或毕业的MSCR、KL或 TL学者和超过75名其他在职学员。ACTSI的支持还为661项科学研究做出了贡献。 出版物，将机构间合作增加了两倍，并在临床领域取得了重要的科学突破 和转化科学。在使命的指引下，“[通过道德社区参与， 教育和培训，以及对发现的创新支持，ACTSI的合作伙伴迅速 并有效地将科学发现转化为影响亚特兰大社区所有人口的科学发现， 五年内，十一个重点功能项目将负责实施三个扩大的具体目标。 目标1：通过跨学科合作促进发现，开发新的和新兴的 技术，药物，设备，诊断和生物制剂，以及这些发现的有效转化， 有益于人类健康。目标2：扩大和改善优秀的方案，教育和培训日益增长的 种族多样的临床科学家骨干，并增加能力和基础设施，以促进 多学科的翻译研究团队。目标3：积极参与社区研究， 使公众信任科学发现和新知识的翻译， 增强我们服务的社区的健康。

To address the CTSA vision to have a sustained and transformative influence on the quality and value of clinical & translational research, leadership from three academic institutions - Emory University, Morehouse School of Medicine, and Georgia Institute of Technology, along with other collaborative organizations formed in 2007, the Atlanta Clinical and Translational Science Institute (ACTSI). The ACTSI has integrated discovery, education, training and community engagement programs and engendered an unprecedented level of transformation in clinical and translational research in our community. The ACTSI has developed an Atlanta "home" for clinical and translational research through support of: 673 investigators, 520 projects, 93 pilot projects in 96 research areas, over 193 federal (PHS) grants, 134 current or graduated MSCR, KL, or TL scholars, and over 75 additional active trainees. ACTSI support has also contributed to 661 scientific publications, tripled inter-institutional collaborations, and led to important scientific breakthroughs in clinical and translational science. Guided by the mission, "[tjhrough ethical community engagement, focused education and training, and innovative support of discovery, the collaborative partners ofthe ACTSI rapidly and efficiently translate scientific discoveries to impact all populations ofthe Atlanta community," in the next five years, eleven key function programs will be charged with implementing three expanded specific aims. Aim 1: Promote discovery through inter-disciplinary collaboration, the development of novel and emerging technologies, drugs, devices, diagnostics and biologies, and the efficient translation of these discoveries to benefit human health. Aim 2: Expand and improve outstanding programs to educate and train a growing cadre of ethnically diverse, clinician scientists, and increase the capacity and infrastructure to foster multidisciplinary translational research teams. Aim 3: Actively engage the community in research that will engender the public trust in scientific discovery and the translation of new knowledge that ultimately enhances the health ofthe communities we serve.